Merck to Lay Off 150 Employees at US Site Due to Gardasil Sales Slump
SOURCENews reportView the filing ↗
What we know
Location: US.
Based on news reporting.
Summary
Merck is set to lay off approximately 150 employees at its US site as a response to declining sales of its Gardasil vaccine. This decision reflects the company's efforts to adjust its workforce in light of the current market conditions impacting the product. The layoffs are part of a broader strategy to streamline operations amid a slump in revenue. The affected employees will be notified as the company moves forward with this workforce reduction.
Merck & Co., Inc. cut 150 jobs as of February 28, 2026.
That is roughly 0.2% of the 70,000 people Merck & Co., Inc. employs.
LayoffTalk has tracked 34 layoff events at Merck & Co., Inc. since May 2025, including 146 jobs documented in official WARN filings, with 31 additional events known from news reporting.
Comments (0)
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Affected by this?
Share your story anonymously — it helps others reading this feel less alone.
Share your story →More layoffs at Merck & Co., Inc.
Recent tracked events at this company.